FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012477550> ?p ?o ?g. }

• W2012477550 endingPage "1308" @default.
• W2012477550 startingPage "1299" @default.
• W2012477550 abstract "Background: In 2000, WHO/UNAIDS recommended co-trimoxazole prophylaxis for persons at early stages of HIV infection (WHO stage ≥ 2) in sub-Saharan Africa. Objective: To assess the cost-effectiveness of alternative strategies for initiation of co-trimoxazole in Côte d’Ivoire. Design: Cost-effectiveness analysis with an HIV simulation model using clinical and cost data from a randomized trial of co-trimoxazole in HIV-infected adults. Methods: The study included HIV-infected patients in Côte d’Ivoire, with median age 33 years. Thirty-four percent were classified as WHO stage 2, 59% as stage 3, and 7% as stage 4. The mean CD4 cell count was 331 × 106 cells/l. The interventions were no prophylaxis, clinical criteria-based co-trimoxazole initiation (early: WHO stage ≥ 2; late: WHO stage ≥ 3), CD4-based co-trimoxazole initiation (< 500, < 200, < 50 × 106 CD4 cells/l). The outcome measures were life expectancy, lifetime costs, and incremental cost-effectiveness. Results: The most effective strategy, initiation of co-trimoxazole prophylaxis at WHO stage ≥ 2, increased undiscounted life expectancy by 5.2 months, discounted life expectancy by 4.4 months, and lifetime costs by US$ 60, compared with no prophylaxis. Delaying prophylaxis initiation until WHO stage ≥ 3 was less costly and less effective. All CD4-based strategies were dominated. The incremental cost-effectiveness of early versus late co-trimoxazole prophylaxis initiation was US$ 200/year of life gained. Results were stable despite wide variations in plausible assumptions about bacterial resistance and the prophylaxis efficacy on co-trimoxazole-resistant strains. Conclusions: For HIV-infected adults in Côte d’Ivoire, co-trimoxazole prophylaxis is reasonably cost-effective and most effective if initiated when WHO stage ≥ 2. Early co-trimoxazole prophylaxis will prevent complications prior to antiretroviral therapy initiation and should be considered an essential component of care for early HIV in sub-Saharan Africa." @default.
• W2012477550 created "2016-06-24" @default.
• W2012477550 creator A5002686651 @default.
• W2012477550 creator A5013015334 @default.
• W2012477550 creator A5019522183 @default.
• W2012477550 creator A5024120430 @default.
• W2012477550 creator A5035400914 @default.
• W2012477550 creator A5042981254 @default.
• W2012477550 creator A5051559780 @default.
• W2012477550 creator A5064601780 @default.
• W2012477550 creator A5067425100 @default.
• W2012477550 creator A5069598808 @default.
• W2012477550 date "2005-08-12" @default.
• W2012477550 modified "2023-09-27" @default.
• W2012477550 title "Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d’Ivoire: a trial-based analysis" @default.
• W2012477550 cites W142030643 @default.
• W2012477550 cites W1950684674 @default.
• W2012477550 cites W1963733265 @default.
• W2012477550 cites W1979331792 @default.
• W2012477550 cites W1990982679 @default.
• W2012477550 cites W1995996976 @default.
• W2012477550 cites W1999500342 @default.
• W2012477550 cites W2001501762 @default.
• W2012477550 cites W2002935662 @default.
• W2012477550 cites W2008795105 @default.
• W2012477550 cites W2026745106 @default.
• W2012477550 cites W2041542511 @default.
• W2012477550 cites W2042387179 @default.
• W2012477550 cites W2043322521 @default.
• W2012477550 cites W2044416560 @default.
• W2012477550 cites W2068407303 @default.
• W2012477550 cites W2072180034 @default.
• W2012477550 cites W2078432415 @default.
• W2012477550 cites W2095230209 @default.
• W2012477550 cites W2101195795 @default.
• W2012477550 cites W2116081403 @default.
• W2012477550 cites W2123436970 @default.
• W2012477550 cites W2124750913 @default.
• W2012477550 cites W2129813277 @default.
• W2012477550 cites W2130060580 @default.
• W2012477550 cites W2132136467 @default.
• W2012477550 cites W2159126559 @default.
• W2012477550 cites W2159324987 @default.
• W2012477550 cites W2171852434 @default.
• W2012477550 doi "https://doi.org/10.1097/01.aids.0000180101.80888.c6" @default.
• W2012477550 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16052085" @default.
• W2012477550 hasPublicationYear "2005" @default.
• W2012477550 type Work @default.
• W2012477550 sameAs 2012477550 @default.
• W2012477550 citedByCount "78" @default.
• W2012477550 countsByYear W20124775502012 @default.
• W2012477550 countsByYear W20124775502013 @default.
• W2012477550 countsByYear W20124775502014 @default.
• W2012477550 countsByYear W20124775502015 @default.
• W2012477550 countsByYear W20124775502016 @default.
• W2012477550 countsByYear W20124775502017 @default.
• W2012477550 countsByYear W20124775502018 @default.
• W2012477550 countsByYear W20124775502019 @default.
• W2012477550 countsByYear W20124775502020 @default.
• W2012477550 crossrefType "journal-article" @default.
• W2012477550 hasAuthorship W2012477550A5002686651 @default.
• W2012477550 hasAuthorship W2012477550A5013015334 @default.
• W2012477550 hasAuthorship W2012477550A5019522183 @default.
• W2012477550 hasAuthorship W2012477550A5024120430 @default.
• W2012477550 hasAuthorship W2012477550A5035400914 @default.
• W2012477550 hasAuthorship W2012477550A5042981254 @default.
• W2012477550 hasAuthorship W2012477550A5051559780 @default.
• W2012477550 hasAuthorship W2012477550A5064601780 @default.
• W2012477550 hasAuthorship W2012477550A5067425100 @default.
• W2012477550 hasAuthorship W2012477550A5069598808 @default.
• W2012477550 hasBestOaLocation W20124775501 @default.
• W2012477550 hasConcept C112930515 @default.
• W2012477550 hasConcept C126322002 @default.
• W2012477550 hasConcept C133925201 @default.
• W2012477550 hasConcept C146357865 @default.
• W2012477550 hasConcept C151730666 @default.
• W2012477550 hasConcept C159110408 @default.
• W2012477550 hasConcept C168563851 @default.
• W2012477550 hasConcept C187212893 @default.
• W2012477550 hasConcept C203014093 @default.
• W2012477550 hasConcept C27415008 @default.
• W2012477550 hasConcept C2776688490 @default.
• W2012477550 hasConcept C2908647359 @default.
• W2012477550 hasConcept C3013748606 @default.
• W2012477550 hasConcept C3019080777 @default.
• W2012477550 hasConcept C535046627 @default.
• W2012477550 hasConcept C71924100 @default.
• W2012477550 hasConcept C86803240 @default.
• W2012477550 hasConcept C99454951 @default.
• W2012477550 hasConceptScore W2012477550C112930515 @default.
• W2012477550 hasConceptScore W2012477550C126322002 @default.
• W2012477550 hasConceptScore W2012477550C133925201 @default.
• W2012477550 hasConceptScore W2012477550C146357865 @default.
• W2012477550 hasConceptScore W2012477550C151730666 @default.
• W2012477550 hasConceptScore W2012477550C159110408 @default.
• W2012477550 hasConceptScore W2012477550C168563851 @default.
• W2012477550 hasConceptScore W2012477550C187212893 @default.
• W2012477550 hasConceptScore W2012477550C203014093 @default.

• next